On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Applied Natural Sciences

InstitutionResearch output, impact & collaborations

Applied Natural Sciences is a institution indexed in ScholarIQ from OpenAlex.

What is known about Applied Natural Sciences?

ScholarIQrecord summary

Applied Natural Sciences is a research organisation in Hamilton, US. OpenAlex records 1,453 works and 38,020 citations for it. 330 researchers list it as their most recent affiliation.

How many works does Applied Natural Sciences have?

ScholarIQindexed works

Applied Natural Sciences has 1,453 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Applied Natural Sciences have?

ScholarIQcitation count

Applied Natural Sciences has 38,020 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Applied Natural Sciences?

ScholarIQresearcher count

Applied Natural Sciences has 330 researchers in the ScholarIQ index.

What is the average h-index at Applied Natural Sciences?

ScholarIQavg h-index

Applied Natural Sciences has an average h-index of 110 in OpenAlex.

What is the ROR of Applied Natural Sciences?

ScholarIQror

The ROR for Applied Natural Sciences is on the source record.

What is the OpenAlex record for Applied Natural Sciences?

ScholarIQopenalex

The OpenAlex for Applied Natural Sciences is on the source record.

Who are the most-cited researchers behind Applied Natural Sciences?

ScholarIQtop researchers by citations
1
Robert J. Mayer · Colorectal Cancer Treatments and Studies
626 works51,235 citations

What are the most-cited papers on Applied Natural Sciences?

ScholarIQmost cited works
Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia
Robert J. Mayer, Roger B. Davis, Charles A. Schiffer, Deborah Berg, Bayard L. Powell, Philip Schulman, George Omura, Joseph O. Moore, O. Ross McIntyre, E Frei
New England Journal of Medicine. 19941,433 CitationsOPEN ACCESS
Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781
Joel E. Tepper, Mark J. Krasna, Donna Niedzwiecki, Donna Hollis, Carolyn E. Reed, Richard M. Goldberg, Krystyna Kiel, Christopher G. Willett, David J. Sugarbaker, Robert J. Mayer
Journal of Clinical Oncology. 20081,363 CitationsOPEN ACCESS
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal Cancer
Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz, Federico Innocenti, Briant Fruth, Jeffrey A. Meyerhardt, Deborah Schrag, Claire Greene, Bert H. O’Neil, James N. Atkins, Scott Berry, Blasé N. Polite, Eileen M. O’Reilly, Richard M. Goldberg, Howard S. Höchster, Richard L. Schilsky, Monica M. Bertagnolli, Anthony B. El-Khoueiry, Peter J. Watson, Al B. Benson, Daniel Mulkerin, Robert J. Mayer, Charles D. Blanke
JAMA. 2017900 CitationsOPEN ACCESS
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
Hedy L. Kindler, Donna Niedzwiecki, Donna Hollis, Susan Sutherland, Deborah Schrag, Herbert I. Hurwitz, Federico Innocenti, Mary F. Mulcahy, Eileen M. O’Reilly, Timothy F. Wozniak, Joel Picus, Pankaj Bhargava, Robert J. Mayer, Richard L. Schilsky, Richard M. Goldberg
Journal of Clinical Oncology. 2010845 CitationsOPEN ACCESS
Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803
Jeffrey A. Meyerhardt, Denise Heseltine, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, James P. Thomas, Heidi Nelson, Renaud Whittom, Alexander Hantel, Richard L. Schilsky, Charles S. Fuchs
Journal of Clinical Oncology. 2006760 Citations

How much of the research on Applied Natural Sciences is open access?

ScholarIQopen access share
73%OPEN ACCESS
Gold
0%
Green
9%
Hybrid
9%
Bronze
55%
Closed
27%

Related on ScholarIQ

470M+ articles · 14-day free trial